首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi

市場調查報告書

商品編碼

1519678

2024-2032 年按類型、疾病、應用、最終用戶和地區分類的病毒載體製造市場報告

Viral Vector Manufacturing Market Report by Type, Disease, Application, End User, and Region 2024-2032

出版日期: 2024年07月01日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球病毒載體製造市場規模達到12.001億美元。

病毒載體是分子生物學家用來將遺傳物質傳遞到細胞的工具。它用於替換有缺陷的基因以治療遺傳性疾病，並表達和呈現致病性抗原以透過模仿自然感染產生免疫反應。它廣泛應用於溶瘤療法中以靶向並殺死腫瘤細胞。除此之外，由於它有助於治療不同的疾病，如心臟缺陷、代謝疾病和神經退化性疾病，因此在生命科學研究、基因治療和疫苗學方面有著廣泛的應用。目前，由於體內基因突變和染色體受損導致的遺傳性疾病盛行率不斷上升，病毒載體的製造增加。

病毒載體製造市場趨勢：

由於個人飲酒量和久坐生活方式的增加，癌症患者不斷增加，這是促進市場成長的關鍵因素之一。此外，全球範圍內針對病毒載體進行的臨床研究數量有所增加。這加上病毒載體在新型藥物傳輸的使用不斷增加，正在對市場產生正面影響。除此之外，它們也是病毒失活序列的有效載體，並用於將抑制 HIV 的基因改造傳遞至人類造血幹細胞 (HSC)。此外，一些國家的政府正在發起運動，以提高個人對病毒載體疫苗的認知。他們也透過快速核准流程等變革來改善監管環境。此外，主要市場參與者正在廣泛投資於全球製造活動的產能擴張。這些企業也熱衷於併購（M&A），預計將提高其整體銷售額和獲利能力。

本報告回答的關鍵問題

2023年全球病毒載體製造市場規模有多大？
2024-2032年全球病毒載體製造市場的預期成長率是多少？
COVID-19 對全球病毒載體製造市場有何影響？
推動全球病毒載體製造市場的關鍵因素是什麼？
全球病毒載體製造市場按類型分類是怎樣的？
基於該疾病的全球病毒載體製造市場的分化是什麼？
基於應用的全球病毒載體製造市場的細分如何？
全球病毒載體製造市場的重點區域有哪些？
全球病毒載體製造市場的主要參與者/公司有哪些？

市場結構
關鍵參與者
關鍵參與者簡介
- Cognate BioServices Inc. (Charles River Laboratories International Inc.)
- F. Hoffmann-La Roche AG
- FinVector Oy
- FUJIFILM Holdings Corporation
- Kaneka Eurogentec SA (Kaneka Corporation)
- Lonza Group AG
- Merck KGaA
- Oxford Biomedica plc
- REGENXBIO Inc.
- Sanofi SA
- Thermo Fisher Scientific Inc.
- uniQure NV

簡介目錄圖表

Product Code: SR112024A5016

The global viral vector manufacturing market size reached US$ 1,200.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,681.6 Million by 2032, exhibiting a growth rate (CAGR) of 22.4% during 2024-2032.

A viral vector is a tool used by molecular biologists for delivering genetic materials into cells. It is used to replace defective genes for curing genetic disorders and express and present pathogenic antigens for generating an immune response by mimicking a natural infection. It is widely employed in oncolytic therapies to target and kill tumor cells. Besides this, as it assists in treating different diseases, such as heart defects, metabolic diseases, and neurodegenerative disorders, it finds extensive applications in life science research, gene therapy and vaccinology. At present, there is a rise in viral vector manufacturing on account of the rising prevalence of genetic disorders due to a combination of gene mutations and damaged chromosomes in the body.

Viral Vector Manufacturing Market Trends:

The increasing cancer patients due to the rising alcohol consumption and sedentary lifestyles of individuals represents one of the key factors contributing to the growth of the market. In addition, there is a rise in the number of clinical studies undertaken on viral vectors across the globe. This, along with the growing utilization of viral vectors in novel drug delivery, is positively influencing the market. Besides this, they are efficient carriers of virus-disabling sequences and are used to deliver HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs). Additionally, governments of several countries are launching campaigns to generate awareness about viral vector vaccines among individuals. They are also improving the regulatory environment via changes, such as fast-track approval processes. Furthermore, key market players are extensively investing in capacity expansion for manufacturing activities around the world. These players are also indulging in mergers and acquisitions (M&A), which is projected to increase their overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global viral vector manufacturing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, disease, application and end user.

Breakup by Type:

Adenoviral Vectors

Adeno-associated Viral Vectors

Lentiviral Vectors

Retroviral Vectors

Others

Breakup by Disease:

Cancer

Genetic Disorders

Infectious Diseases

Others

Breakup by Application:

Gene Therapy

Vaccinology

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.

Key Questions Answered in This Report

1. What was the size of the global viral vector manufacturing market in 2023?
2. What is the expected growth rate of the global viral vector manufacturing market during 2024-2032?
3. What has been the impact of COVID-19 on the global viral vector manufacturing market?
4. What are the key factors driving the global viral vector manufacturing market?
5. What is the breakup of the global viral vector manufacturing market based on the type?
6. What is the breakup of the global viral vector manufacturing market based on the disease?
7. What is the breakup of the global viral vector manufacturing market based on the application?
8. What are the key regions in the global viral vector manufacturing market?
9. Who are the key players/companies in the global viral vector manufacturing market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Viral Vector Manufacturing Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Adenoviral Vectors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Adeno-associated Viral Vectors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Lentiviral Vectors
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Retroviral Vectors
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Disease

7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Genetic Disorders
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Infectious Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Application

8.1 Gene Therapy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Vaccinology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical and Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Cognate BioServices Inc. (Charles River Laboratories International Inc.)
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 F. Hoffmann-La Roche AG
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
- 15.3.3 FinVector Oy
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 FUJIFILM Holdings Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Kaneka Eurogentec S.A. (Kaneka Corporation)
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Lonza Group AG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Merck KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Oxford Biomedica plc
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 REGENXBIO Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 uniQure N.V.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Viral Vector Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Viral Vector Manufacturing Market: Breakup by Type (in %), 2023
Figure 5: Global: Viral Vector Manufacturing Market: Breakup by Disease (in %), 2023
Figure 6: Global: Viral Vector Manufacturing Market: Breakup by Application (in %), 2023
Figure 7: Global: Viral Vector Manufacturing Market: Breakup by End User (in %), 2023
Figure 8: Global: Viral Vector Manufacturing Market: Breakup by Region (in %), 2023
Figure 9: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Viral Vector Manufacturing (Retroviral Vectors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Viral Vector Manufacturing (Retroviral Vectors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Viral Vector Manufacturing (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Viral Vector Manufacturing (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Viral Vector Manufacturing (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Viral Vector Manufacturing (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Viral Vector Manufacturing (Genetic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Viral Vector Manufacturing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Viral Vector Manufacturing (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Viral Vector Manufacturing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Viral Vector Manufacturing (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Viral Vector Manufacturing (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Viral Vector Manufacturing (Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Viral Vector Manufacturing (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Viral Vector Manufacturing (Vaccinology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Viral Vector Manufacturing (Vaccinology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Viral Vector Manufacturing (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Viral Vector Manufacturing (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North America: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: United States: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: United States: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Canada: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Canada: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Asia-Pacific: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Asia-Pacific: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: China: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: China: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Japan: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Japan: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: India: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: India: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: South Korea: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: South Korea: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Australia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Australia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Indonesia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Indonesia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Europe: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Europe: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Germany: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Germany: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: France: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: France: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: United Kingdom: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: United Kingdom: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Italy: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Italy: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Spain: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Spain: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Russia: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Russia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Latin America: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Latin America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Brazil: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Brazil: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Mexico: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Mexico: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Others: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Middle East and Africa: Viral Vector Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Middle East and Africa: Viral Vector Manufacturing Market: Breakup by Country (in %), 2023
Figure 83: Middle East and Africa: Viral Vector Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Global: Viral Vector Manufacturing Industry: SWOT Analysis
Figure 85: Global: Viral Vector Manufacturing Industry: Value Chain Analysis
Figure 86: Global: Viral Vector Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Viral Vector Manufacturing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Viral Vector Manufacturing Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Viral Vector Manufacturing Market Forecast: Breakup by Disease (in Million US$), 2024-2032
Table 4: Global: Viral Vector Manufacturing Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Viral Vector Manufacturing Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Viral Vector Manufacturing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Viral Vector Manufacturing Market: Competitive Structure
Table 8: Global: Viral Vector Manufacturing Market: Key Players

02-2729-4219

+886-2-2729-4219